These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 24891325)
1. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. Asmussen S; Ito H; Traber DL; Lee JW; Cox RA; Hawkins HK; McAuley DF; McKenna DH; Traber LD; Zhuo H; Wilson J; Herndon DN; Prough DS; Liu KD; Matthay MA; Enkhbaatar P Thorax; 2014 Sep; 69(9):819-25. PubMed ID: 24891325 [TBL] [Abstract][Full Text] [Related]
2. Combined Mesenchymal Stromal Cell Therapy and Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Randomized Controlled Trial in Sheep. Millar JE; Bartnikowski N; Passmore MR; Obonyo NG; Malfertheiner MV; von Bahr V; Redd MA; See Hoe L; Ki KK; Pedersen S; Boyle AJ; Baillie JK; Shekar K; Palpant N; Suen JY; Matthay MA; McAuley DF; Fraser JF Am J Respir Crit Care Med; 2020 Aug; 202(3):383-392. PubMed ID: 32293914 [No Abstract] [Full Text] [Related]
3. Effects of nebulized adipose-derived mesenchymal stem cells on acute lung injury following smoke inhalation in sheep. Niimi Y; Baljinnyam T; Fukuda S; Andersen CR; Salsbury JR; Lee JO; Prough DS; Enkhbaatar P Int Immunopharmacol; 2023 Oct; 123():110638. PubMed ID: 37494838 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis. Maybauer MO; Maybauer DM; Fraser JF; Traber LD; Westphal M; Enkhbaatar P; Cox RA; Huda R; Hawkins HK; Morita N; Murakami K; Mizutani A; Herndon DN; Traber DL Crit Care Med; 2006 Sep; 34(9):2432-8. PubMed ID: 16810106 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell-derived exosomes for treatment of sepsis. Homma K; Bazhanov N; Hashimoto K; Shimizu M; Heathman T; Hao Q; Nawgiri R; Muthukumarana V; Lee JW; Prough DS; Enkhbaatar P Front Immunol; 2023; 14():1136964. PubMed ID: 37180159 [TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Devaney J; Horie S; Masterson C; Elliman S; Barry F; O'Brien T; Curley GF; O'Toole D; Laffey JG Thorax; 2015 Jul; 70(7):625-35. PubMed ID: 25986435 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe Park J; Kim S; Lim H; Liu A; Hu S; Lee J; Zhuo H; Hao Q; Matthay MA; Lee JW Thorax; 2019 Jan; 74(1):43-50. PubMed ID: 30076187 [TBL] [Abstract][Full Text] [Related]
8. R-100 improves pulmonary function and systemic fluid balance in sheep with combined smoke-inhalation injury and Pseudomonas aeruginosa sepsis. Ito H; Malgerud E; Asmussen S; Lopez E; Salzman AL; Enkhbaatar P J Transl Med; 2017 Dec; 15(1):266. PubMed ID: 29282084 [TBL] [Abstract][Full Text] [Related]
14. Cepharanthin, an alkaloid from Stephania cepharantha, inhibits increased pulmonary vascular permeability in an ovine model of sepsis. Murakami K; Cox RA; Hawkins HK; Schmalstieg FC; McGuire RW; Jodoin JM; Traber LD; Traber DL Shock; 2003 Jul; 20(1):46-51. PubMed ID: 12813368 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary microvascular hyperpermeability and expression of vascular endothelial growth factor in smoke inhalation- and pneumonia-induced acute lung injury. Lange M; Hamahata A; Traber DL; Connelly R; Nakano Y; Traber LD; Schmalstieg FC; Herndon DN; Enkhbaatar P Burns; 2012 Nov; 38(7):1072-8. PubMed ID: 22647495 [TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]